A pill that combines four different medicines and could halve deaths from heart attack and stroke around the globe will enter human trials.
Basically, [big pharmaceutical companies'] whole business model is people paying [hundreds of dollars] a year for the latest blockbuster drug. A pill with established medicines that halved cardiovascular risk and could be available for [$40] a year could be seen as a threat."
http://www.guardian.co.uk/society/2008/sep/29/health.medicalresearch
No comments:
Post a Comment